BioNTech SE (LON:0A3M)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in USD
87.00
-1.16 (-1.32%)
At close: Nov 10, 2026

BioNTech SE Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,473-1,136-665.3930.39,43410,293
Depreciation & Amortization
368.4185.3156.6183.4123.375.2
Loss (Gain) From Sale of Assets
-1.9-2.5-0.33.80.64.6
Asset Writedown & Restructuring Costs
516.1197.5141.4---
Loss (Gain) From Sale of Investments
-10.4-10.44.6175.5-24157.3
Stock-Based Compensation
62.680.9-53.6-714.856.880.5
Other Operating Activities
515.1603.5-596.3-781.6-315.21,110
Change in Accounts Receivable
386.31,084387.75,3744,370-11,808
Change in Inventory
159.9177.974.581.962.9-438.4
Change in Accounts Payable
-753.7-723.8758.4118.985.71,516
Operating Cash Flow
-230.8456207.75,37113,577889.7
Operating Cash Flow Growth
-119.55%-96.13%-60.44%1426.07%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-208.2-175.1-286.5-250.1-329.2-127.5
Sale of Property, Plant & Equipment
7.14.51.2-0.63.4
Cash Acquisitions
233186.3--336.9--20.8
Sale (Purchase) of Intangibles
-36.7-573.9-165.8-455.4-34.1-26.5
Investment in Securities
637.4-1,910-1,630-5,912327.4-394.7
Investing Cash Flow
632.6-2,469-2,081-6,955-35.3-566.1

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-6.7-0.30.8-
Long-Term Debt Repaid
--57.6-45.9-40.4-59.9-66.7
Lease Payments
-44.8-39.6-43.6-40.3-41.1-14.1
Net Debt Issued (Repaid)
76.5-50.9-45.9-40.1-59.1-66.7
Issuance of Common Stock
----110.5163.6
Repurchase of Common Stock
-403.5---738.5-986.4-
Other Financing Activities
-2-2----2.7
Financing Cash Flow
-329-52.9-45.9-778.6-1,41994.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-3.3-2714.8-14.560.164.7
Miscellaneous Cash Flow Adjustments
38.45.92.8164.8-0.5-
Net Cash Flow
107.9-2,087-1,902-2,21112,182482.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-439280.9-78.85,12113,248762.2
Free Cash Flow Growth
----61.34%1638.15%-
Free Cash Flow Margin
-18.14%9.79%-2.86%134.10%76.53%4.02%
Free Cash Flow Per Share
-1.751.16-0.3321.1053.032.94
Levered Free Cash Flow
-1,592-1,098-548.24,13912,009-646.6
Unlevered Free Cash Flow
-1,583-1,089-537.644,14312,020-629.54
Free Cash Flow After Leases
-483.8241.3-122.45,08113,207748.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
11.21113.55.421.512.2
Cash Income Tax Paid
50.9-3.8389.2482.94,2223,458
Change in Working Capital
-207.5537.81,2215,5754,519-10,730